Qatar Oral Solid Dosage Cdmo Market Size & Outlook

The oral solid dosage cdmo market in Qatar is expected to reach a projected revenue of US$ 162.5 million by 2033. A compound annual growth rate of 4.6% is expected of Qatar oral solid dosage cdmo market from 2025 to 2033.
Revenue, 2024 (US$M)
$108.5
Forecast, 2033 (US$M)
$162.5
CAGR, 2025 - 2033
4.6%
Report Coverage
Qatar

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Qatar oral solid dosage cdmo market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Qatar oral solid dosage cdmo market highlights

  • The Qatar oral solid dosage cdmo market generated a revenue of USD 108.5 million in 2024 and is expected to reach USD 162.5 million by 2033.
  • The Qatar market is expected to grow at a CAGR of 4.6% from 2025 to 2033.
  • In terms of segment, tablets was the largest revenue generating product in 2024.
  • Capsules is the most lucrative product segment registering the fastest growth during the forecast period.


Oral solid dosage cdmo market data book summary

Market revenue in 2024USD 108.5 million
Market revenue in 2033USD 162.5 million
Growth rate4.6% (CAGR from 2025 to 2033)
Largest segmentTablets
Fastest growing segmentCapsules
Historical data2021 - 2023
Base year2024
Forecast period2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationTablets, Capsules, Powders, Granules, Others Product
Key market players worldwideCatalent Inc, Lonza Group Ltd, Kuehne + Nagel International AG, Boehringer Ingelheim, Thermo Fisher Scientific Inc, Siegfried Holding AG, AbbVie Inc, Chemical Works of Gedeon Richter PLC, Jubilant Pharmova, Piramal Pharma Solutions, Recipharm, CordenPharma, Alcami, DPT Laboratories, SPI Pharma, Quotient Sciences, Rubicon Research, Almac Group, Aenova Group


Other key industry trends

  • In terms of revenue, Qatar accounted for 0.2% of the global oral solid dosage cdmo market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Middle East & Africa, South Africa oral solid dosage cdmo market is projected to lead the regional market in terms of revenue in 2033.
  • UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 387.6 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Oral Solid Dosage CDMO Market Companies

Name Profile # Employees HQ Website
Rubicon Research View profile 251-500 Mumbai, Maharashtra, India, Asia http://www.rubicon.co.in/
SPI Pharma View profile 251-500 Wilmington, Delaware, United States, North America http://spipharma.com
Aenova Group View profile 5001-10000 Greensboro, North Carolina, United States, North America http://www.aenova-group.com
Quotient Sciences View profile 251-500 Nottingham, Nottingham, United Kingdom, Europe https://www.quotientsciences.com/
Jubilant Pharmova View profile 10001+ Noida, Uttar Pradesh, India, Asia https://www.jubilantpharmova.com
DPT Laboratories View profile 1001-5000 San Antonio, Texas, United States, North America https://www.dptlabs.com
Almac Group View profile 1001-5000 Craigavon, Craigavon, United Kingdom, Europe https://www.almacgroup.com
CordenPharma View profile 5001-10000 Plankstadt, Baden-Wurttemberg, Germany, Europe http://cordenpharma.com
Alcami View profile 501-1000 Wilmington, North Carolina, United States, North America http://www.alcaminow.com
Piramal Pharma Solutions View profile 1001-5000 Riverview, Michigan, United States, North America http://www.piramalpharmasolutions.com/
Recipharm View profile 1001-5000 Jordbro, Stockholms Lan, Sweden, Europe http://www.recipharm.com
Chemical Works of Gedeon Richter PLC View profile 11901 Gyomroi ut 19-21, Budapest, Hungary, 1103 https://www.gedeonrichter.com/hu-hu
Siegfried Holding AG View profile 4180 Untere Bruehlstrasse 4, Zofingen, Switzerland, CH-4800 https://www.siegfried.ch
Catalent Inc View profile 17219 14 Schoolhouse Road, Somerset, NJ, United States, 08873 https://www.catalent.com
Kuehne + Nagel International AG View profile 93064 Dorfstrasse 50, P.O. Box 67, Schindellegi, Switzerland, CH-8834 http://www.kuehne-nagel.com
Boehringer Ingelheim View profile 10001+ Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe https://www.boehringer-ingelheim.com/
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
Lonza Group Ltd View profile 18000 Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 https://www.lonza.com
AbbVie Inc View profile 50000 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 http://www.abbvieinvestor.com

Qatar oral solid dosage cdmo market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oral solid dosage cdmo market will help companies and investors design strategic landscapes.


Tablets was the largest segment with a revenue share of 32.81% in 2024. Horizon Databook has segmented the Qatar oral solid dosage cdmo market based on tablets, capsules, powders, granules, others product covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to Qatar oral solid dosage cdmo market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Qatar oral solid dosage cdmo market databook

  • Our clientele includes a mix of oral solid dosage cdmo market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Qatar oral solid dosage cdmo market , including forecasts for subscribers. This country databook contains high-level insights into Qatar oral solid dosage cdmo market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Qatar oral solid dosage cdmo market size, by product, 2021-2033 (US$M)

Qatar Oral Solid Dosage CDMO Market Outlook Share, 2024 & 2033 (US$M)

Qatar oral solid dosage cdmo market size, by product, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online